{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:28:08Z","timestamp":1789576088292,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T00:00:00Z","timestamp":1445817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T00:00:00Z","timestamp":1445817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mildly elevated bilirubin is associated with a reduction in the presence and progression of chronic kidney disease and related mortality, which may be attributed to bilirubin\u2019s antioxidant properties. This study investigated whether endogenously elevated bilirubin would protect against adenine-induced kidney damage in male hyperbilirubinaemic Gunn rats and littermate controls. Animals were orally administered adenine or methylcellulose solvent (vehicle) daily for 10 days and were then monitored for 28 days. Serum and urine were assessed throughout the protocol for parameters of kidney function and antioxidant\/oxidative stress status and kidneys were harvested for histological examination upon completion of the study. Adenine-treated animals experienced weight-loss, polyuria and polydipsia; however, these effects were significantly attenuated in adenine-treated Gunn rats. No difference in the presence of dihydroadenine crystals, lymphocytic infiltration and fibrosis were noted in Gunn rat kidneys versus controls. However, plasma protein carbonyl and F\n                    <jats:sub>2<\/jats:sub>\n                    -isoprostane concentrations were significantly decreased in Gunn rats versus controls, with no change in urinary 8-oxo-7,8-dihydro-2\u2032-deoxyguanosine or kidney tissue F\n                    <jats:sub>2<\/jats:sub>\n                    -isoprostane concentrations. These data indicated that endogenously elevated bilirubin specifically protects from systemic oxidative stress in the vascular compartment. These data may help to clarify the protective relationship between bilirubin, kidney function and cardiovascular mortality in clinical investigations.\n                  <\/jats:p>","DOI":"10.1038\/srep15482","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T05:20:10Z","timestamp":1445836810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure"],"prefix":"10.1038","volume":"5","author":[{"given":"Ai-Ching","family":"Boon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris F.","family":"Benzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Briskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff S.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Fassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Bulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,26]]},"reference":[{"key":"BFsrep15482_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2369-10-34","volume":"10","author":"N Takamatsu","year":"2009","unstructured":"Takamatsu, N. et al. Risk factors for chronic kidney disease in Japan: a community-based study. BMC Nephrol 10, 34 (2009).","journal-title":"BMC Nephrol"},{"key":"BFsrep15482_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.diabres.2009.01.009","volume":"84","author":"R Yamamoto","year":"2009","unstructured":"Yamamoto, R. et al. Association between atherosclerosis and newly classified chronic kidney disease stage for Japanese patients with type 2 diabetes. Diabetes Res Clin Pract 84, 39\u201345 (2009).","journal-title":"Diabetes Res Clin Pract"},{"key":"BFsrep15482_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2215\/CJN.06130710","volume":"6","author":"YH Chen","year":"2011","unstructured":"Chen, Y. H., Hung, S. C. & Tarng, D. C. Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients. Clin J Am Soc Nephrol 6, 567\u2013574 (2011).","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFsrep15482_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1464-5491.2010.03173.x","volume":"28","author":"M Fukui","year":"2011","unstructured":"Fukui, M. et al. Low serum bilirubin concentration in haemodialysis patients with Type 2 diabetes. Diabetic Med 28, 96\u201399 (2011).","journal-title":"Diabetic Med"},{"key":"BFsrep15482_CR5","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.2337\/db13-1652","volume":"63","author":"IJ Riphagen","year":"2014","unstructured":"Riphagen, I. J. et al. Bilirubin and progression of nephropathy in type 2 diabetes: a post hoc analysis of RENAAL with independent replication in IDNT. Diabetes 63, 2845\u20132853 (2014).","journal-title":"Diabetes"},{"key":"BFsrep15482_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.atherosclerosis.2014.03.015","volume":"234","author":"M Tanaka","year":"2014","unstructured":"Tanaka, M. et al. Low serum bilirubin concentration is a predictor of chronic kidney disease. Atherosclerosis 234, 421\u2013425 (2014).","journal-title":"Atherosclerosis"},{"key":"BFsrep15482_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000339027","volume":"36","author":"E Oda","year":"2012","unstructured":"Oda, E., Aoyagi, R. & Aizawa, Y. Hypobilirubinemia might be a possible risk factor of end-stage kidney disease independently of estimated glomerular filtration rate. Kidney Blood Press Res 36, 47\u201354 (2012).","journal-title":"Kidney Blood Press Res"},{"key":"BFsrep15482_CR8","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.3346\/jkms.2009.24.S1.S22","volume":"24","author":"HJ Chin","year":"2009","unstructured":"Chin, H. J. et al. The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy. J Korean Med Sci 24 Suppl, S22\u201329 (2009).","journal-title":"J Korean Med Sci"},{"key":"BFsrep15482_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.33549\/physiolres.932127","volume":"61","author":"HM Dvorakova","year":"2012","unstructured":"Dvorakova, H. M. et al. Determinants of premature atherosclerosis in children with end-stage renal disease. Physiol Res 61, 53\u201361 (2012).","journal-title":"Physiol Res"},{"key":"BFsrep15482_CR10","doi-asserted-by":"publisher","first-page":"F123","DOI":"10.1152\/ajprenal.00039.2014","volume":"307","author":"AC Boon","year":"2014","unstructured":"Boon, A. C., Bulmer, A. C., Coombes, J. S. & Fassett, R. G. Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations. Am J Physiol Renal Physiol 307, F123\u2013F136 (2014).","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFsrep15482_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20140566","volume":"129","author":"K-H Wagner","year":"2015","unstructured":"Wagner, K.-H. et al. Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases. Clin Sci (Lond) 129, 1\u201325 (2015).","journal-title":"Clin Sci (Lond)"},{"key":"BFsrep15482_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/10715768909073428","volume":"6","author":"R Stocker","year":"1989","unstructured":"Stocker, R. & Peterhans, E. Antioxidant properties of conjugated bilirubin and biliverdin: biologically relevant scavenging of hypochlorous acid. Free Radic Res Commun 6, 57\u201366 (1989).","journal-title":"Free Radic Res Commun"},{"key":"BFsrep15482_CR13","doi-asserted-by":"crossref","first-page":"16712","DOI":"10.1016\/S0021-9258(19)89449-8","volume":"269","author":"J Neuzil","year":"1994","unstructured":"Neuzil, J. & Stocker, R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 269, 16712\u201316719 (1994).","journal-title":"J Biol Chem"},{"key":"BFsrep15482_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2007.11.022","volume":"199","author":"AC Bulmer","year":"2008","unstructured":"Bulmer, A. C., Blanchfield, J. T., Toth, I., Fassett, R. G. & Coornbes, J. S. Improved resistance to serum oxidation in Gilbert\u2019s syndrome: A mechanism for cardiovascular protection. Atherosclerosis 199, 390\u2013396 (2008).","journal-title":"Atherosclerosis"},{"key":"BFsrep15482_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ajmg.10209","volume":"108","author":"KY Fertrin","year":"2002","unstructured":"Fertrin, K. Y., Goncalves, M. S., Saad, S. T. & Costa, F. F. Frequencies of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil. Am J Med Genet 108, 117\u2013119 (2002).","journal-title":"Am J Med Genet"},{"key":"BFsrep15482_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1478-3231.2008.01716.x","volume":"28","author":"J Fevery","year":"2008","unstructured":"Fevery, J. Bilirubin in clinical practice: a review. Liver Int 28, 592\u2013605 (2008).","journal-title":"Liver Int"},{"key":"BFsrep15482_CR17","first-page":"175286","volume":"2014","author":"M do Sameiro-Faria","year":"2014","unstructured":"do Sameiro-Faria, M. et al. Potential Cardiovascular Risk Protection of Bilirubin in End-Stage Renal Disease Patients under Hemodialysis. Biomed Res Int 2014, 175286 (2014).","journal-title":"Biomed Res Int"},{"key":"BFsrep15482_CR18","doi-asserted-by":"publisher","first-page":"F778","DOI":"10.1152\/ajprenal.00215.2004","volume":"288","author":"CA Adin","year":"2005","unstructured":"Adin, C. A., Croker, B. P. & Agarwal, A. Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney. Am J Physiol Renal Physiol 288, F778\u2013784 (2005).","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFsrep15482_CR19","doi-asserted-by":"publisher","first-page":"F888","DOI":"10.1152\/ajprenal.00064.2006","volume":"292","author":"K Kirkby","year":"2007","unstructured":"Kirkby, K. et al. Intravenous bilirubin provides incomplete protection against renal ischemia-reperfusion injury in vivo. Am J Physiol Renal Physiol 292, F888\u2013894 (2007).","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFsrep15482_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/CAD.0b013e3282fdc391","volume":"19","author":"K Barabas","year":"2008","unstructured":"Barabas, K. et al. Hyperbilirubinemia\u2019s protective effect against cisplatin nephrotoxicity in the Gunn rat. Anticancer Drugs 19, 495\u2013502 (2008).","journal-title":"Anticancer Drugs"},{"key":"BFsrep15482_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1471-2369-14-105","volume":"14","author":"SW Oh","year":"2013","unstructured":"Oh, S. W. et al. Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosis. BMC Nephrol 14, 105 (2013).","journal-title":"BMC Nephrol"},{"key":"BFsrep15482_CR22","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1093\/ndt\/gfp711","volume":"25","author":"SH Nasr","year":"2010","unstructured":"Nasr, S. H. et al. Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure. Nephrol Dial Transplant 25, 1909\u20131915 (2010).","journal-title":"Nephrol Dial Transplant"},{"key":"BFsrep15482_CR23","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1111\/ajt.12926","volume":"14","author":"M Zaidan","year":"2014","unstructured":"Zaidan, M. et al. Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure. Am J Transplant 14, 2623\u20132632 (2014).","journal-title":"Am J Transplant"},{"key":"BFsrep15482_CR24","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/j.1476-5381.2008.00108.x","volume":"156","author":"K Terai","year":"2009","unstructured":"Terai, K. et al. Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels. Br J Pharmacol 156, 1267\u20131278 (2009).","journal-title":"Br J Pharmacol"},{"key":"BFsrep15482_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s101570050015","volume":"3","author":"H Okada","year":"1999","unstructured":"Okada, H. et al. Reversibility of adenine-induced renal failure in rats. Clin Exp Nephrol 3, 82\u201388 (1999).","journal-title":"Clin Exp Nephrol"},{"key":"BFsrep15482_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.vascn.2013.05.006","volume":"68","author":"V Diwan","year":"2013","unstructured":"Diwan, V., Mistry, A., Gobe, G. & Brown, L. Adenine-induced chronic kidney and cardiovascular damage in rats. J Pharmacol Toxicol Methods 68, 197\u2013207 (2013).","journal-title":"J Pharmacol Toxicol Methods"},{"key":"BFsrep15482_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00418-009-0557-5","volume":"131","author":"M Tamura","year":"2009","unstructured":"Tamura, M., Aizawa, R., Hori, M. & Ozaki, H. Progressive renal dysfunction and macrophage infiltration in interstitial fibrosis in an adenine-induced tubulointerstitial nephritis mouse model. Histochem Cell Biol 131, 483\u2013490 (2009).","journal-title":"Histochem Cell Biol"},{"key":"BFsrep15482_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1440-1797.2007.00844.x","volume":"13","author":"K Terai","year":"2008","unstructured":"Terai, K., Mizukami, K. & Okada, M. Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model. Nephrology (Carlton) 13, 139\u2013146 (2008).","journal-title":"Nephrology (Carlton)"},{"key":"BFsrep15482_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1159\/000299794","volume":"31","author":"N Shobeiri","year":"2010","unstructured":"Shobeiri, N., Adams, M. A. & Holden, R. M. Vascular calcification in animal models of CKD: A review. Am J Nephrol 31, 471\u2013481 (2010).","journal-title":"Am J Nephrol"},{"key":"BFsrep15482_CR30","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1681\/ASN.2006030240","volume":"17","author":"RW Schrier","year":"2006","unstructured":"Schrier, R. W. Body Water Homeostasis: Clinical Disorders of Urinary Dilution and Concentration. J Am Soc Nephrol 17, 1820\u20131832 (2006).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep15482_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/bjaceaccp\/mki042","volume":"5","author":"SS Rassam","year":"2005","unstructured":"Rassam, S. S. & Counsell, D. J. Perioperative electrolyte and fluid balance. Continuing Education in Anaesthesia, Critical Care & Pain 5, 157\u2013160 (2005).","journal-title":"Continuing Education in Anaesthesia, Critical Care & Pain"},{"key":"BFsrep15482_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3126\/nje.v1i5.6154","volume":"1","author":"B Poudel","year":"2011","unstructured":"Poudel, B. et al. Estimation and Comparison of Serum Levels of Sodium, Potassium, Calcium and Phosphorus in Different Stages of Chronic Kidney Disease. Nepal J Epidemiol 1, 160\u2013167 (2011).","journal-title":"Nepal J Epidemiol"},{"key":"BFsrep15482_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1523-1755.2005.00386.x","volume":"68","author":"A-M Kuusniemi","year":"2005","unstructured":"Kuusniemi, A.-M. et al. Kidneys with heavy proteinuria show fibrosis, inflammation and oxidative stress, but no tubular phenotypic change. Kidney Int 68, 121\u2013132 (2005).","journal-title":"Kidney Int"},{"key":"BFsrep15482_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.clinbiochem.2011.03.137","volume":"44","author":"SS Huang","year":"2011","unstructured":"Huang, S. S., Huang, P. H., Chiang, K. H., Chen, J. W. & Lin, S. J. Association of serum bilirubin levels with albuminuria in patients with essential hypertension. Clin Biochem 44, 859\u2013863 (2011).","journal-title":"Clin Biochem"},{"key":"BFsrep15482_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2369-12-29","volume":"12","author":"HS Shin","year":"2011","unstructured":"Shin, H. S., Jung, Y. S. & Rim, H. Relationship of serum bilirubin concentration to kidney function and 24-hour urine protein in Korean adults. BMC Nephrol 12, 29 (2011).","journal-title":"BMC Nephrol"},{"key":"BFsrep15482_CR36","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1681\/ASN.2006091006","volume":"18","author":"BC Kwan","year":"2007","unstructured":"Kwan, B. C., Kronenberg, F., Beddhu, S. & Cheung, A. K. Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol 18, 1246\u20131261 (2007).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep15482_CR37","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.freeradbiomed.2012.03.002","volume":"52","author":"AC Boon","year":"2012","unstructured":"Boon, A. C. et al. Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome. Free Radic Biol Med 52, 2120\u20132127 (2012).","journal-title":"Free Radic Biol Med"},{"key":"BFsrep15482_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/CS20120661","volume":"125","author":"M Wallner","year":"2013","unstructured":"Wallner, M. et al. Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert\u2019s syndrome. Clin Sci (Lond) 125, 257\u2013264 (2013).","journal-title":"Clin Sci (Lond)"},{"key":"BFsrep15482_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1523-1755.2003.00126.x","volume":"64","author":"K Katsumata","year":"2003","unstructured":"Katsumata, K. et al. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int 64, 441\u2013450 (2003).","journal-title":"Kidney Int"},{"key":"BFsrep15482_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1440-1797.2009.01161.x","volume":"15","author":"R Ikeda","year":"2010","unstructured":"Ikeda, R., Imai, Y., Maruyama, W. & Mizoguchi, K. Systemic disorders of calcium dynamics in rats with adenine-induced renal failure: implication for chronic kidney disease-related complications. Nephrology (Carlton) 15, 54\u201362 (2010).","journal-title":"Nephrology (Carlton)"},{"key":"BFsrep15482_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.atherosclerosis.2009.02.010","volume":"206","author":"M Tanaka","year":"2009","unstructured":"Tanaka, M. et al. Low serum bilirubin concentration is associated with coronary artery calcification (CAC). Atherosclerosis 206, 287\u2013291 (2009).","journal-title":"Atherosclerosis"},{"key":"BFsrep15482_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/clc.21964","volume":"35","author":"ZY Zhang","year":"2012","unstructured":"Zhang, Z. Y., Bian, L. Q., Kim, S. J., Zhou, C. C. & Choi, Y. H. Inverse relation of total serum bilirubin to coronary artery calcification score detected by multidetector computed tomography in males. Clin Cardiol 35, 301\u2013306 (2012).","journal-title":"Clin Cardiol"},{"key":"BFsrep15482_CR43","first-page":"131","volume":"47","author":"K Hagym\u00e1si","year":"2003","unstructured":"Hagym\u00e1si, K. et al. Further evidence of altered redox status of hyperbilirubinaemic patients: role of bilirubin in Gilbert syndrome. Acta Biol Szeged 47, 131\u2013134 (2003).","journal-title":"Acta Biol Szeged"},{"key":"BFsrep15482_CR44","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","volume":"65","author":"BP Oberg","year":"2004","unstructured":"Oberg, B. P. et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65, 1009\u20131016 (2004).","journal-title":"Kidney Int"},{"key":"BFsrep15482_CR45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/089686080902900211","volume":"29","author":"D Zwoli\u0144ska","year":"2009","unstructured":"Zwoli\u0144ska, D. et al. Oxidative stress in children on peritoneal dialysis. Peritoneal Dialysis International 29, 171\u2013177 (2009).","journal-title":"Peritoneal Dialysis International"},{"key":"BFsrep15482_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.freeradbiomed.2015.05.031","volume":"86","author":"AC Boon","year":"2015","unstructured":"Boon, A. C., Hawkins, C. L., Coombes, J. S., Wagner, K. H. & Bulmer, A. C. Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein\/lipid oxidation in physiologically relevant hyperbilirubinemic serum. Free Radic Biol Med 86, 259\u2013268 (2015).","journal-title":"Free Radic Biol Med"},{"key":"BFsrep15482_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00726-003-0016-x","volume":"25","author":"CL Hawkins","year":"2003","unstructured":"Hawkins, C. L., Pattison, D. I. & Davies, M. J. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 25, 259\u2013274 (2003).","journal-title":"Amino Acids"},{"key":"BFsrep15482_CR48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10157-009-0161-y","volume":"13","author":"Y Matsuyama","year":"2009","unstructured":"Matsuyama, Y., Terawaki, H., Terada, T. & Era, S. Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney disease. Clin Exp Nephrol 13, 308\u2013315 (2009).","journal-title":"Clin Exp Nephrol"},{"key":"BFsrep15482_CR49","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/ndt\/gfl007","volume":"21","author":"C Capeill\u00e8re-Blandin","year":"2006","unstructured":"Capeill\u00e8re-Blandin, C. et al. Respective role of uraemic toxins and myeloperoxidase in the uraemic state. Nephrol Dial Transplant 21, 1555\u20131563 (2006).","journal-title":"Nephrol Dial Transplant"},{"key":"BFsrep15482_CR50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3233\/CH-131739","volume":"54","author":"G Caimi","year":"2013","unstructured":"Caimi, G., Carollo, C., Hopps, E., Montana, M. & Lo Presti, R. Protein oxidation in chronic kidney disease. Clin Hemorheol Microcirc 54, 409\u2013413 (2013).","journal-title":"Clin Hemorheol Microcirc"},{"key":"BFsrep15482_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/1354750X.2012.749302","volume":"18","author":"PS Tucker","year":"2013","unstructured":"Tucker, P. S., Dalbo, V. J., Han, T. & Kingsley, M. I. Clinical and research markers of oxidative stress in chronic kidney disease. Biomarkers 18, 103\u2013115 (2013).","journal-title":"Biomarkers"},{"key":"BFsrep15482_CR52","doi-asserted-by":"publisher","first-page":"9748","DOI":"10.1073\/pnas.85.24.9748","volume":"85","author":"B Frei","year":"1988","unstructured":"Frei, B., Stocker, R. & Ames, B. N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 85, 9748\u20139752 (1988).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep15482_CR53","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0891-5849(95)00032-S","volume":"19","author":"PA Dennery","year":"1995","unstructured":"Dennery, P. A., Mcdonagh, A. F., Spitz, D. R., Rodgers, P. A. & Stevenson, D. K. Hyperbilirubinemia Results in Reduced Oxidative Injury in Neonatal Gunn-Rats Exposed to Hyperoxia. Free Radic Bio Med 19, 395\u2013404 (1995).","journal-title":"Free Radic Bio Med"},{"key":"BFsrep15482_CR54","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrneph.2011.149","volume":"7","author":"Y Liu","year":"2011","unstructured":"Liu, Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7, 684\u2013696 (2011).","journal-title":"Nat Rev Nephrol"},{"key":"BFsrep15482_CR55","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.bbagen.2013.06.009","volume":"1840","author":"HE Poulsen","year":"2014","unstructured":"Poulsen, H. E., Nadal, L. L., Broedbaek, K., Nielsen, P. E. & Weimann, A. Detection and interpretation of 8-oxodG and 8-oxoGua in urine, plasma and cerebrospinal fluid. Biochim Biophys Acta 1840, 801\u2013808 (2014).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep15482_CR56","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/j.1476-5381.2011.01413.x","volume":"164","author":"AC Bulmer","year":"2011","unstructured":"Bulmer, A. C. et al. Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration. Brit J Pharmacol 164, 1857\u20131870 (2011).","journal-title":"Brit J Pharmacol"},{"key":"BFsrep15482_CR57","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0003-2697(76)90326-2","volume":"74","author":"PJ Hissin","year":"1976","unstructured":"Hissin, P. J. & Hilf, R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74, 214\u2013226 (1976).","journal-title":"Anal Biochem"},{"key":"BFsrep15482_CR58","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.freeradbiomed.2009.01.007","volume":"46","author":"CL Hawkins","year":"2009","unstructured":"Hawkins, C. L., Morgan, P. E. & Davies, M. J. Quantification of protein modification by oxidants. Free Radic Biol Med 46, 965\u2013988 (2009).","journal-title":"Free Radic Biol Med"},{"key":"BFsrep15482_CR59","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jpba.2013.11.028","volume":"90","author":"DR Briskey","year":"2014","unstructured":"Briskey, D. R., Wilson, G. R., Fassett, R. G. & Coombes, J. S. Optimized method for quantification of total F(2)-isoprostanes using gas chromatography-tandem mass spectrometry. J Pharm Biomed Anal 90, 161\u2013166 (2014).","journal-title":"J Pharm Biomed Anal"},{"key":"BFsrep15482_CR60","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cca.2009.12.013","volume":"411","author":"KF Lee","year":"2010","unstructured":"Lee, K. F., Chung, W. Y. & Benzie, I. F. Urine 8-oxo-7,8-dihydro-2\u2032-deoxyguanosine (8-oxodG), a specific marker of oxidative stress, using direct, isocratic LC-MS\/MS: Method evaluation and application in study of biological variation in healthy adults. Clin Chim Acta 411, 416\u2013422 (2010).","journal-title":"Clin Chim Acta"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep15482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep15482","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep15482.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T09:53:40Z","timestamp":1672912420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep15482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,26]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,7]]}},"alternative-id":["BFsrep15482"],"URL":"https:\/\/doi.org\/10.1038\/srep15482","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,26]]},"assertion":[{"value":"27 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15482"}}